CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

BackgroundEarly high-efficacy treatment for people with relapsing multiple sclerosis (pwRMS) may provide better long-term outcomes compared with the escalation strategy. In this study, we present an analysis of treatment success and safety from the CONFIDENCE study in a real-world cohort of pwRMS tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Mathias Buttmann, Martin S. Weber, Sven G. Meuth, Sandra Blümich, Stefanie Hieke-Schulz, Petra Dirks, Julius C. Eggebrecht, Tjalf Ziemssen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Neurology
Subjects:
Relapsing multiple sclerosis
humanized monoclonal anti-CD20 antibody
neurodegenerative diseases
non-interventional study (NIS)
ocrelizumab
real-world cohort
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1564327/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1564327/full

Similar Items